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Supplementary Methods
Population-based GWAS samples, phenotype measurement.
This section describes study-specific characteristics that are not presented in the tables. All participants provided written informed consent and studies were approved by local Research Ethics Committees and/or Institutional Review boards.
The Baltimore Longitudinal Study of Aging (BLSA) is an ongoing prospective study of human aging which started in 1958 1 . The study recruited volunteers predominantly from Washington DC and Baltimore MD, USA. Healthy volunteers aged >17 years were recruited; there were no exclusion criteria. Only European-origin individuals were included in the analysis. Blood pressure was measured using a mercury sphygmomanometer in the seated position, the average of the 2nd and 3rd readings were recorded for both the right and left arm.
The British 1958 Birth cohort -Type 1 Diabetes Genetics Consortium (B58C-T1DGC) is a sample from the national population-based sample followed periodically from birth to age 44-45 years http://www.b58cgene.sgul.ac.uk/collection.php); 2,580 individuals were included in this analysis. Blood pressure was recorded using the Omron 705CP machine three times, seated. The average of three readings was used for the analysis.
The British 1958 Birth cohort -Wellcome Trust Case Control Consortium (B58C-WTCCC) is a second sample from the national population-based sample followed periodically from birth to age 44-45 years (http://www.b58cgene.sgul.ac.uk/collection.php); 1,473 individuals were included in the analysis and are distinct from individuals included in the B58C-T1DGC cohort. Blood pressure was recorded using the Omron 705CP machine three times, seated. The average of three readings was used for the analysis.
Cohorte Lausannoise (CoLaus) is a population-based study aimed at assessing the prevalence and molecular determinants of cardiovascular risk factors in the Caucasian population of Lausanne, Switzerland 2 . Participants in the study (4, 969) were randomly selected from the population register of Lausanne in 2003 (n=56,694, aged 35-75 years). All individuals were of Caucasian origin, defined as having both parents and grandparents born in a defined list of European countries. Blood pressure was measured using the Omron HEM-907 machine, in the seated position. Three measures were taken on the left arm; the mean of the last two measures was used in the analyses.
The European Prospective Investigation of Cancer-Norfolk-Genome Wide Association Study (EPIC-Norfolk-GWAS) study includes 3,847 participants with genome-wide genotyping data nested within the EPIC-Norfolk Study, a populationbased cohort study of 25,663 Europid men and women aged 39-79 years recruited in Norfolk, UK between 1993 and 1997 3, 4 . The 2,100 non-obese individuals were included in stage 1. Blood pressure was measured using the Accutorr oscillometric BP machine; the mean of two readings was taken and used in the analysis.
The Fenland Study is an ongoing population-based cohort study designed to investigate the association between genetic and lifestyle environmental factors and the risk of obesity, insulin sensitivity, hyperglycemia and related metabolic traits in Global BPgen Supplement page 28 men and women aged 30 to 55 yrs. Volunteers were recruited from General Practice sampling frames in the Fenland, Ely and Cambridge areas of the Cambridgeshire Primary Care Trust in the U.K. The study currently comprises more than 3,000 participants; 1,500 volunteers were genotyped and included in the current analyses. Blood pressure was measured using an Accutorr automated sphygmomanometer; the average of three measurements made at one minute intervals in the seated position was used for this analysis.
The Invecchiare in Chianti (InCHIANTI) study is a representative populationbased study of older people living in the Chianti area of Tuscany, Italy 5 . All participants were >21 years of age and of white European origin. Blood pressure was measured using a mercury sphygmomanometer in the supine position; the average of the 2nd and 3rd readings was used for the analysis.
Kooperative Gesundheitsforschung in der Region Augsburg (KORA) (third survey: S3/F3) is an epidemiological cohort recruited from the general population of Augsburg, Germany in 1994-1995 6, 7 . A subset of this survey (1,644 subjects) participated in this study (http://epi.helmholtz-muenchen.de/kora-gen/). Subjects with BMI<35 kg/m 2 were included; diabetics were excluded. Blood pressure was measured using a random zero sphygmomanometer in the seated position at the first examination cycle; the mean of two readings was used.
The North Finland Birth Cohort of 1966 (NFBC1966, n=12,058 live born) was designed to study factors affecting preterm birth, low birth weight, and subsequent morbidity and mortality (http://kelo.oulu.fi/NFBC/). The longitudinal data collection includes clinical examination and blood sampling at age 31 years, from which data in the current study are drawn. The attendees in the follow-up (71% response rate) were adequately representative of the original cohort 8 as is the final study sample in the present analyses. Blood pressure was measured using a mercury sphygmomanometer, seated, from the right arm after 15 minutes rest. The average of two readings taken 5 minutes apart was used for the analyses. Both questionnaire and national medication reimbursement data were used for antihypertensive medication information.
The SardiNIA study is a longitudinal study examining age-related quantitative traits in individuals from the Ogliastra region of Sardinia, Italy 9 . The SardiNIA GWAS examined 4,305 related individuals (age >14 years), of whom 3,998 individuals were included in this study. Blood pressure was measured using a mercury sphygmomanometer; the average of the second and third reading was used for the analyses.
The Study of Health in Pomerania (SHIP) study is a population-based survey in West Pomerania, the north-east area of Germany 10 . A sample from the adult population aged 20 to 79 years was drawn based on population registries of cities and towns in the region. SHIP finally comprised 4,310 participants (corresponding to a final response rate of 68.8%). 3,310 individuals with GWAS data were included in this study. Blood pressure was measured three times, seated, after 5 minutes of rest, using a digital blood pressure monitor (HEM-705CP, Omron Corporation, Tokyo, Japan), after a rest period of 3 minutes for each measurement. The mean of the second and third measurements was used in the analyses.
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The Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) study is a longitudinal study performed on a national sample of healthy volunteers from France between 1996 and 2001. 1,823 individuals, aged 35-65 years at baseline were included in this study 11 . Blood pressure was measured using a mercury sphygmomanometer in the seated position; the average of three readings taken from the first examination (1996) was used in the analysis.
The TwinsUK Study comprises a sample of 1,195 healthy female Caucasians recruited through the TwinsUK registry in London (http://www.twinresearch.ac.uk/indexscience.html). All participants were recruited from the general population without presence or interest in any particular disease or trait through national media campaigns. One of each twin pair was selected, with ages ranging from 18 to 76 years. Blood pressure was measured using the Omron HEM-907 machine, seated. Three readings were taken, the first was discarded and the average of the other two was used in the analyses.
Control GWAS samples from case-control studies, phenotype measurement.
The Diabetes Genetics Initiative (DGI) is a type 2 diabetes (T2D) casecontrol study of Swedish and Finnish individuals matched on age, gender and BMI 12 . The 1,467 normoglycemic male and female controls were included in the stage 1 Global BPgen analysis. Blood pressure traits were the average of two seated measurements using a mercury sphygmomanometer.
The Finland-United States Investigation of NIDDM Genetics (FUSION) study aims to discover variants predisposing to T2D and T2D-related quantitative traits (http://fusion.sph.umich.edu/) 13, 14 . The FUSION GWAS sample includes 1,161 Finnish T2D cases and 1,174 normal glucose tolerant (NGT) controls and 122 offspring of case/control pairs (1T2D, 119 NGT, 2 with impaired glucose tolerance). The controls and NGT offspring were used in stage 1 of the Global BPgen analysis. The blood pressure trait was the average of two seated measurements using a mercury sphygmomanometer after 5 minutes of rest 15 . FUSION analyses were adjusted for birth province.
The Myocardial Infarction Genetics Consortium (MIGen) cohort is composed of a subset of the controls of a case-control study aimed at identifying genetic variants associated with early-onset myocardial infarction. Most of the controls are selected from population based cross-sectional or cohort studies and come from five different studies: Heart Attack Risk in Puget Sound (Seattle, USA), REGICOR (Girona, Spain), MGH Premature Coronary Artery Disease Study (Boston, USA), FINRISK (Finland); Malmö Diet and Cancer Study (Malmö, Sweden). For the majority of studies, blood pressure was measured twice using calibrated sphygmomanometers, in the seated position after at least 5 minutes of rest; the mean of the two measurements was used in the analysis.
The Precocious Coronary Artery Disease (PROCARDIS, www.procardis.org) study is a European consortium investigating the genetics of precocious coronary artery disease (CAD) in German, Italian, Swedish and British CAD patients and controls 16 . Country of origin was a covariate in all analyses. The controls included in Global BPgen Supplement page 30 this study had no personal history of CAD, hypertension or diabetes. Blood pressure was measured twice using various sphygmomanometers, in the seated position after at least 5 minutes of rest; the mean of the two measurements was used.
Stage 2a Replication samples and phenotype measurement.
The Utrecht Atherosclerosis Risk in Young Adults (ARYA) study is a cross sectional population-based birth cohort designed to assess predictors of cardiovascular events in young adults 17 . It includes 750 young adults, born in 1970-1973 in Utrecht, The Netherlands. Blood pressure was measured using a Dinamap machine. An average of 4 seated readings (two from the first visit and two from a second visit, mean 20 days apart) was used for the analysis.
The BRIGHT study is a hypertension case-control study (www.brightstudy.ac.uk) 18 . 2,445 hypertensive cases and 673 normotensive controls were included in this study. Case inclusion criterion was a diagnosis of hypertension prior to 50 years of age (BRIGHT-HTN). Exclusion criteria included BMI>35, diabetes, secondary hypertension or a co-existing illness. Normotensive controls (BRIGHT-NT) had blood pressure recordings of SBP ≤120mmHg and DBP≤ 85mmHg and were not taking any anti-hypertensive medications. Blood pressure was measured in both cohorts using the OMRON-705CP blood pressure monitor, the mean of three blood pressure recordings in the seated position was used in the analysis.
The EPIC-Italy study is a longitudinal cohort of 10,603 volunteers, aged 35-64 years at baseline, from the Turin area, Italy 19 . Individuals were excluded if they had anamnesis of cancer. Blood pressure was measured using a mercury sphygmomanometer, seated, in the left arm. 4,111 healthy subjects of both genders were included in this study.
The European Prospective Investigation of Cancer-Norfolk-replication cohort (EPIC-Norfolk-REP) includes 15,858 participants who were not part of the genomewide scan in EPIC-Norfolk. These individuals were used for stage 2a follow-up; cohort details and blood pressure measurements are the same as described above for EPIC-Norfolk-GWAS.
The Finland-United States Investigation of NIDDM Genetics (FUSION2) controls (n=1,162) are an independent sample from the FUSION study, these were used for stage 2a follow-up genotyping; cohort details and blood pressure measurements are same as described above for the FUSION study.
Finrisk97 is a population-based, cross-sectional survey conducted in 1997 designed to study the prevalence of cardiovascular risk factors in Finland. Genotypes were available in 7,023 men and women free of exclusions. Blood pressures in Finrisk97 were averaged from 2 measures using a mercury column sphygmomanometer in seated participants resting for at least 5 minutes 15 .
The London Life Sciences Population (LOLIPOP) study is an ongoing populationbased cohort study of ~30,000 individuals (18,000 Indian Asians and 12,000 European white men and women), aged 35-75 years and recruited from the lists of 58 General Practitioners in West London, United Kingdom 20, 21 . In the present study, Global BPgen Supplement page 31 DNA was available for 18,829 participants. Blood pressure was measured using an Omron 705CP sphygmomanometer (mean of 3 measurements) with the subject seated. Indian Asian analyses were adjusted for self-reported religion.
The Malmö Diet and Cancer (MDC) study is a community-based prospective epidemiologic cohort of 28,449 persons recruited for a baseline examination between 1991 and 1996. From this cohort, 6,103 persons were randomly selected to participate in the Cardiovascular Cohort (MDC-CC), which seeks to investigate risk factors for cardiovascular disease 22 . Blood pressure was measured using a mercury sphygmomanometer once after 10 minutes of rest in the supine position.
The METabolic Syndrome In Men (METSIM) study includes men aged 45-72 years, randomly selected from the population of the town of Kuopio, Eastern Finland, Finland (population 95,000) 23, 24 . The present analysis is based on the first ~6,200 subjects examined for METSIM. Blood pressure was measured in the seated position after 5 minutes rest using a mercury sphygmomanometer. The average of 3 measurements was used in the analysis.
The Malmö Preventive Project (MPP) is a screening program for cardiovascular risk factors and comprises 33,346 Swedish subjects (22,444 men and 10,902 women) from the city of Malmö in southern Sweden 25 . There are 14,600 with DNA after removing subjects who were also participants in MDC-CC (see above). Blood pressure was measured using a mercury sphygmomanometer (mean of 2 measurements) after 10 minutes of rest supine.
The Prevention of REnal and Vascular ENd stage Disease (PREVEND) study, is an ongoing prospective study investigating the natural course of increased levels of urinary albumin excretion and its relation to renal and cardiovascular disease. Inhabitants 28 to 75 years of age (n=85,421) in the city of Groningen, The Netherlands were asked to complete a short questionnaire; 47% responded, and individuals were then selected with a urinary albumin concentration of at least 10 mg/L (n = 7,768) and a randomly selected control group with a urinary albumin concentration less than 10 mg/L (n = 3,395). Details of the protocol have been described elsewhere 26, 27 . Blood pressure was measured in the supine position every minute for 10 and 8 minutes, respectively, with an automatic DINAMAP XL Model 9300 series monitor (Critikon, Tampa, Florida). Systolic and diastolic blood pressures were calculated as the mean of the last two measurements at the two visits.
The Prospect-EPIC cohort is one of the two Dutch contributions to the European Prospective Investigation into Cancer and Nutrition (EPIC) 28 . Participants were recruited between 1993 and 1997 among women living in Utrecht and its vicinity and who attended the regional population-based breast cancer screening program. A total of 17,357 women aged 49-70 years were included. For laboratory analysis a 10% random sample of 1,736 samples was taken. Blood pressure was measured using an automated and calibrated Oscillomat (Bosch & Son, Jungingen, Germany); the average of two readings after 10 minutes rest in the seated position was used for the analysis.
The Utrecht Health Project (UHP) is a prospective cohort of 2,829 individuals conducted in a newly developed residential area in the Netherlands (Leidsche Global BPgen Supplement page 32 Rijn) 29 . Blood pressure was measured using an Omron M4 machine, in the seated position; the average of 2 readings was used in the current analysis.
Stage 2a follow-up genotyping. For cohorts EPIC-Italy, MPP, MDC-CC, and EPIC-Norfolk-REP we used Taqman assays. For Finrisk97, FUSION2 and METSIM samples genotyping was performed using the iPLEX Sequenom MassARRAY platform. For all remaining studies we performed genotyping at KBiosciences using the KASPAR assay. All SNPs were in Hardy-Weinberg equilibrium (p>0.001) with call rate >90%.
